If you live with or have lost a loved one to Alzheimer’s disease you may find yourself with an inbox filled with well-intentioned emails from family and friends, about the latest research on Alzheimer’s disease or the new cure that drug companies don’t want you to know about. A recent New York Times article hits a bit differently. Linde Jacobs is a woman in her 30s with two young daughters. Four weeks ago, she lost her mother to frontal temporal dementia (FTD) and the article begins with her waiting to hear her genetic test result, that is whether she has…
Read More
Nicotinamide Results from Dr. Joshua Grill's Nicotinamide as an Early Alzheimer's Disease Treatment (NEAT), a phase 2 clinical trial of nicotinamide in early Alzheimer's, were recently published in Neurology and highlighted in PsyPost, an online psychology news outlet. To read the article published in PsyPost, click here.
Read More
